PP_1170x120_10-25-21

AllianceRx Walgreens Pharmacy granted exclusive access to Phospholine Iodide

Print Friendly, PDF & Email

ORLANDO, Fla. — AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide (echothiophate iodide for ophthalmic solution) from Fera Pharmaceuticals. Phospholine Iodide is used to help reduce elevated intraocular pressure of glaucoma and for accommodative esotropia (the inward turning of the eye) in children.

AllianceRx Walgreens Pharmacy Logo

“AllianceRx Walgreens Pharmacy is excited to be able to offer this invaluable therapeutic option to help correct these chronic and rare ophthalmologic conditions,” says Lisa Mymo, vice president, pharma and financial services at AllianceRx Walgreens Pharmacy. “These patients deserve access to this life-changing therapy that may actually preserve their vision. Our manufacturer partners know we offer resources to help patients stay on therapy and yield the best possible outcomes.”

As one of the nation’s largest specialty and home delivery pharmacies, AllianceRx Walgreens Pharmacy has direct access to the majority of limited distribution drugs on the market. In addition to Phospholine Iodide, the following medications are also available through AllianceRx Walgreens Pharmacy:

Camzyos (mavacamten), manufactured by Bristol Myers Squibb, treats adults with a rare heart condition known as symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms.
Vivjoa (oteseconazole), manufactured by Mycovia Pharmaceuticals, Inc., treats postmenopausal and permanently infertile women with recurrent vaginal yeast infections.
For full prescribing information or black box warnings, visit the manufacturer’s websites or dailymed.nlm.nih.gov.


ECRM-08-202222

Adheris Health

Comments are closed.

Adheris Health